当前位置: X-MOL 学术Int. J. Neuropsychopharmacol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Treatment discontinuation impact on long-term (10-years) weight gain and lipid metabolism in first-episode psychosis: results from the PAFIP-10 cohort.
International Journal of Neuropsychopharmacology ( IF 4.5 ) Pub Date : 2020-08-25 , DOI: 10.1093/ijnp/pyaa066
Javier Vázquez-Bourgon 1, 2, 3 , Jaqueline Mayoral-van Son 2, 4 , Marcos Gómez-Revuelta 1, 3 , María Juncal-Ruiz 3, 5 , Víctor Ortiz-García de la Foz 1 , Diana Tordesillas-Gutiérrez 1, 2, 3 , Rosa Ayesa-Arriola 1, 2, 3 , Miquel Bioque 2, 6 , Benedicto Crespo-Facorro 2, 4
Affiliation  

Patients with a first episode of psychosis (FEP) are at higher risk of gaining weight and presenting metabolic disturbances, partly related to antipsychotic exposure. Previous studies suggest that treatment discontinuation might have a positive impact on weight in schizophrenia. The aim of this study is to evaluate the effect of treatment discontinuation on weight and metabolic changes in a FEP cohort.

中文翻译:

治疗中止对首发精神病患者长期(10 年)体重增加和脂质代谢的影响:来自 PAFIP-10 队列的结果。

首次发作精神病 (FEP) 的患者体重增加和出现代谢紊乱的风险较高,部分与抗精神病药物暴露有关。先前的研究表明,停止治疗可能对精神分裂症患者的体重产生积极影响。本研究的目的是评估停药对 FEP 队列中体重和代谢变化的影响。
更新日期:2020-08-25
down
wechat
bug